Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Houhui Shi"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Tumor metabolism and tumor immunity are inextricably linked. Targeting the metabolism of tumors is a point worth studying in tumor immunotherapy. Recently, the influence of the metabolism of tumors and immune cells on the occurrence, proliferation, m
Externí odkaz:
https://doaj.org/article/bc2378bb49ce4269914fb025a3d9f220
Autor:
Kai Li, Houhui Shi, Benxia Zhang, Xuejin Ou, Qizhi Ma, Yue Chen, Pei Shu, Dan Li, Yongsheng Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-25 (2021)
Abstract Myeloid-derived suppressor cells (MDSCs) are a heterogenic population of immature myeloid cells with immunosuppressive effects, which undergo massive expansion during tumor progression. These cells not only support immune escape directly but
Externí odkaz:
https://doaj.org/article/47a422efbf89417e92290ad0d8f3b6e1
Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
Autor:
Yuan Cheng, Fei Mo, Qingfang Li, Xuejiao Han, Houhui Shi, Siyuan Chen, Yuquan Wei, Xiawei Wei
Publikováno v:
Molecular Cancer, Vol 20, Iss 1, Pp 1-21 (2021)
Abstract Background Drug-resistance and severe side effects of chemotherapeutic agents result in unsatisfied survival of patients with lung cancer. CXCLs/CXCR2 axis plays an important role in progression of cancer including lung cancer. However, the
Externí odkaz:
https://doaj.org/article/b71a9641a5094bebb5cd9232066ff7f1
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
T lymphocytes function as major players in antigen-mediated cytotoxicity and have become powerful tools for exploiting the immune system in tumor elimination. Several types of T cell-based immunotherapies have been prescribed to cancer patients with
Externí odkaz:
https://doaj.org/article/f4c1c0ff29124dabb92a2b0399a93231
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Cancer cells resistance to various therapies remains to be a key challenge nowadays. For a long time, scientists focused on tumor cells themselves for the mechanisms of acquired drug resistance. However, recent evidence showed that tumor microenviron
Externí odkaz:
https://doaj.org/article/b175ed5901024cc1b792cabcfdcf1f0f
Autor:
Xiawei Wei, An Tong, Yang Yang, Ruyu Pi, Xia Zhao, Tianqi Lu, Xiaoyi Hu, Houhui Shi, Hongyi Li, Yuquan Wei, Xi Wang, Yu Liu
Publikováno v:
Cancer Letters. 523:72-81
Mechanistic target of rapamycin (mTOR) forms two distinct complexes, mTOR complex 1 (mTORC1) and mTORC2. Here we investigated the antitumor effect of dual mTORC1/2 inhibitor AZD2014 on epithelial ovarian cancer (EOC) and its potential effect on immun
Autor:
Xuejin Ou, Dan Li, Kai Li, Yue Chen, Houhui Shi, Yongsheng Wang, Benxia Zhang, Qizhi Ma, Pei Shu
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-25 (2021)
Signal Transduction and Targeted Therapy
Signal Transduction and Targeted Therapy
Myeloid-derived suppressor cells (MDSCs) are a heterogenic population of immature myeloid cells with immunosuppressive effects, which undergo massive expansion during tumor progression. These cells not only support immune escape directly but also pro
Autor:
Xin He, Fan Tang, Chongqi Tu, Yi Luo, Xiawei Wei, Jingyun Yang, Yong Zhou, Li Min, Houhui Shi, Siyuan Chen, Yan Tie, Weiqi Hong
Publikováno v:
Annals of Surgical Oncology. 28:6453-6463
Tenosynovial giant cell tumor (TGCT) is a locally aggressive tumor with colony-stimulating factor 1 receptor (CSF1R) signal expression. However, there is a lack of better in vivo and ex vivo models for TGCT. This study aims to establish a favorable p
Autor:
Cheng, Yuan, Mo, Fei, Qingfang Li, Xuejiao Han, Houhui Shi, Siyuan Chen, Yuquan Wei, Wei, Xiawei
Additional file 6: Supplementary Table 1. Primers for quantitative real-time PCR.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8d974d3778d674640e2bb8eef9d89e
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Cancer cells resistance to various therapies remains to be a key challenge nowadays. For a long time, scientists focused on tumor cells themselves for the mechanisms of acquired drug resistance. However, recent evidence showed that tumor microenviron